Bicalutamide, sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer. It is typically...
216 KB (21,601 words) - 09:16, 19 July 2024
pharmacology of bicalutamide is the study of the pharmacodynamic and pharmacokinetic properties of the nonsteroidal antiandrogen (NSAA) bicalutamide. In terms...
185 KB (20,447 words) - 15:57, 1 August 2024
The side effects of bicalutamide, a nonsteroidal antiandrogen (NSAA), including its frequent and rare side effects, have been well-studied and characterized...
140 KB (15,722 words) - 03:49, 24 June 2024
Comparison of the nonsteroidal antiandrogen (NSAA) bicalutamide with other antiandrogens reveals differences between the medications in terms of efficacy...
85 KB (8,742 words) - 03:27, 16 August 2024
The medical uses of bicalutamide, a nonsteroidal antiandrogen (NSAA), include the treatment of androgen-dependent conditions and hormone therapy to block...
133 KB (13,441 words) - 19:13, 1 February 2024
Vergunst H, Mulders PF (2016). "The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally...
31 KB (3,433 words) - 01:04, 23 June 2024
5N-Bicalutamide, or 5-azabicalutamide, is a highly potent nonsteroidal antiandrogen (NSAA) which was discovered in 2016. It is a structural modification...
5 KB (400 words) - 10:45, 3 November 2023
high-dosage bicalutamide therapy plus dutasteride showed less sexual dysfunction than medical castration similarly to high-dosage bicalutamide monotherapy...
48 KB (5,709 words) - 11:12, 22 June 2024
to bicalutamide where the expression was upregulated. In VCaP cells which over-express the AR, enzalutamide induced apoptosis whereas bicalutamide did...
50 KB (4,674 words) - 21:27, 12 July 2024
treatments. When castration is combined with a nonsteroidal antiandrogen like bicalutamide, this strategy is referred to as combined androgen blockade (also known...
158 KB (15,043 words) - 06:11, 3 August 2024
skin Avoiding damaging skin with harsh grooming or chemical irritants Bicalutamide, an antiandrogen, has been observed in one patient to have potentially...
34 KB (3,429 words) - 17:31, 18 August 2024
use. Like spironolactone, flutamide is typically only used by women. Bicalutamide is another option for the treatment of female pattern hair loss. It has...
68 KB (7,160 words) - 18:52, 24 February 2024
Alternatively, the combination of the androgen receptor antagonist bicalutamide and the aromatase inhibitor anastrozole may be used. Robert King Stone...
4 KB (323 words) - 21:58, 23 April 2024
receptor with a very high affinity with an IC50 of 0.28 nM. Reference drug bicalutamide had an IC50 of 3.1 nM. Saceda-Corralo D, Domínguez-Santas M, Vañó-Galván...
5 KB (258 words) - 17:03, 30 June 2024
(FDA) approved it for use the treatment of prostate cancer. In 1995, bicalutamide was approved, and nilutamide followed a year later. The AR belongs to...
42 KB (4,594 words) - 12:17, 24 February 2024
medication has largely been replaced by newer and improved NSAAs, namely bicalutamide and enzalutamide, due to their better efficacy, tolerability, safety...
99 KB (10,959 words) - 06:32, 12 May 2024
antiandrogens such as nonsteroidal antiandrogens like flutamide, nilutamide, and bicalutamide; and androgen synthesis inhibitors such as ketoconazole and abiraterone...
24 KB (2,462 words) - 20:32, 3 July 2024
AD, Bruins JL, et al. (2016). "The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally...
51 KB (4,969 words) - 08:21, 27 July 2024
at a dosage of 0.5 to 1 mg/day in combination with the antiandrogen bicalutamide in the treatment of peripheral precocious puberty, for instance due to...
27 KB (2,332 words) - 04:27, 27 February 2024
tamoxifen used for the treatment of breast cancer while the antiandrogen bicalutamide alone or in combination with castration is used to treat prostate cancer...
8 KB (950 words) - 16:28, 12 June 2022
bicalutamide L02BA01 Tamoxifen L02BA02 Toremifene L02BA03 Fulvestrant L02BA04 Elacestrant L02BB01 Flutamide L02BB02 Nilutamide L02BB03 Bicalutamide L02BB04...
2 KB (239 words) - 00:26, 31 December 2023
Other dermatological preparations (D11) Anti-seborrheics Antiandrogens Bicalutamide Cyproterone acetate Flutamide Spironolactone Antifungals Bifonazole Cetrimonium...
3 KB (290 words) - 18:49, 24 February 2024
Other dermatological preparations (D11) Anti-seborrheics Antiandrogens Bicalutamide Cyproterone acetate Flutamide Spironolactone Antifungals Bifonazole Cetrimonium...
48 KB (4,531 words) - 16:25, 31 July 2024
benign prostatic hypertrophy (BPH), using the nonsteroidal antiandrogen bicalutamide as a lead compound. Development of andarine for all indications has been...
10 KB (958 words) - 17:14, 4 July 2024
Other dermatological preparations (D11) Anti-seborrheics Antiandrogens Bicalutamide Cyproterone acetate Flutamide Spironolactone Antifungals Bifonazole Cetrimonium...
50 KB (5,493 words) - 21:20, 29 July 2024
Naltrexone Nicardipine Nonsteroidal antiandrogens (e.g., apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide) Oenanthotoxin Pentylenetetrazol...
37 KB (3,826 words) - 05:00, 11 August 2024
Other dermatological preparations (D11) Anti-seborrheics Antiandrogens Bicalutamide Cyproterone acetate Flutamide Spironolactone Antifungals Bifonazole Cetrimonium...
23 KB (2,330 words) - 16:48, 11 May 2024
Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide Budesonide/formoterol Budesonide/glycopyrronium...
41 KB (3,439 words) - 18:35, 12 August 2024
160 mg/day enzalutamide and mean (R)-bicalutamide levels of 21.6 μg/mL (50.2 μmol/L) for 150 mg/day bicalutamide. The mean volume of distribution of apalutamide...
36 KB (3,026 words) - 22:35, 16 August 2024
in chemical structure to nilutamide, which is related to flutamide, bicalutamide, and enzalutamide, all of which are NSAAs similarly. RU-58841 can be...
6 KB (533 words) - 18:51, 25 October 2023